Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology

CANNANNEW REPORT

Agreement to explore the use of Silo Pharma’s Novel Peptide Englewood Cliffs, NJ, April 07, 2021 (GLOBE NEWSWIRE) — Silo… Read More…..

Excerpt only …
READ MORE BELOW
Source : Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.